How much funding has Avelas Biosciences raised?

Avelas Biosciences has raised $34.3M in total funding, most recently a series c round.

Who are Avelas Biosciences's investors?

Avelas Biosciences's investors include Avalon Ventures, Pharmstandard, Torrey Pines Investment, WuXi AppTec.

When was Avelas Biosciences founded?

Avelas Biosciences was founded in 2008.

Where is Avelas Biosciences headquartered?

Avelas Biosciences is headquartered in San Diego, California, United States.

What industry is Avelas Biosciences in?

Avelas Biosciences operates in Medtech, Biotech, Health Care, Medical Device.

How many employees does Avelas Biosciences have?

Avelas Biosciences has 11-50 employees.

Avelas Biosciences

San Diego, United States · Founded 2008 · $34.3M raised

Medtech

Biotech

Health Care

Medical Device

Headquarters: San Diego, California
Employees: 11–50
Founded: 2008
Website: avelasbio.com

Total Funding: $34.3M
Last Round: $20.0M Series CMar 2017
Rounds: 3

About

Avelas Biosciences is a San Diego biotechnology company developing fluorescence-guided imaging technology to improve cancer surgery. Founded in 2008 by Avalon Ventures around science from Nobel laureate Roger Tsien, Avelas created a real-time tumor-visualization agent designed to help surgeons distinguish cancerous from healthy tissue during operations, aiming to reduce repeat surgeries and improve outcomes. The company has advanced its lead candidate through clinical development backed by Series B and Series C financings.

Summary

Avelas Biosciences is a Medtech company based in San Diego, United States, founded in 2008. It has raised $34.3M in total across 3 rounds, most recently a $20.0M Series C round in Mar 2017. Investors include Avalon Ventures, Pharmstandard and Torrey Pines Investment.